Skip to content
Recruiting

APA (Adapted Physical Activity) for Patients With Advanced Melanoma

About this study

APA (adapted physical activity) for patients with advanced melanoma APA (adapted physical activity) for patients with advanced melanoma undergoing treatment: evaluation of a personalized program at the hospital Melanoma is a malignant tumor developed from melanocytes. It accounts for approximately 4% of all incident cancers and 1.2% of cancer deaths, regardless of sex. Since 2011, the advent of new therapies (targeted therapies and immunotherapies) has revolutionized the management of advanced-stage melanoma (unresectable stage III or stage IV). These treatments have led to a significant improvement in the prognosis of metastatic melanoma, with a 5-year overall survival rate of 34% for targeted therapies, 44% for monotherapy with immunotherapy, and 52% for the combination of nivolumab + ipilimumab. Due to the improvement in survival rates, advanced melanoma has become a chronic disease affecting all ages. It is therefore essential to maintain the quality of life for these patients.

Condition
Melanoma of Skin
Sponsor
University Hospital, Rouen

Who can join

Age
18 years and older
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 7

  • Minimum age: 18 years
  • Study condition: Melanoma of Skin
  • Male or female patient aged 18 or older
  • Advanced melanoma treated adjuvantly or curatively with immunotherapy or targeted therapy
  • Patient who has read and understood the information letter and does not object to participating in the study
  • Member of or beneficiary of a social security scheme
  • Patients who have agreed to participate in the adapted sports module

Exclusion 4

  • Minor patient
  • Melanoma not requiring systemic treatment
  • Condition making 6-month follow-up impossible
  • Protected incapacitated persons (judicial protection, guardianship, curatorship, deprivation of liberty)

Where

1 site, 1 recruiting

University Rouen Hospital

Rouen, France

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.